Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $57.2640 (-0.36%) ($56.8550 - $57.7458) on Tue. Oct. 4, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 0.9% (three month average) | RSI | 49 | Latest Price | $57.2640(-0.36%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.5% a day on average for past five trading days. | Weekly Trend | ABBV declines -0.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(61%) VYM(49%) IVE(47%) IWD(46%) SPY(46%) | Factors Impacting ABBV price | ABBV will decline at least -0.45% in a week (0% probabilities). VIXM(-18%) TLT(-14%) UUP(-9%) IPO(-4%) IGOV(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.45% (StdDev 0.9%) | Hourly BBV | 0 () | Intraday Trend | -0.5% | | | |
|
Resistance Level | $57.94 | 5 Day Moving Average | $57.51(-0.43%) | 10 Day Moving Average | $58.06(-1.37%) | 20 Day Moving Average | $57.94(-1.17%) | To recent high | -6.5% | To recent low | 2.6% | Market Cap | $101.03b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |